News
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...
Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...
Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...
2d
Pharmaceutical Technology on MSNPluri’s immune cell expansion technologies gain patentsBiotechnology company Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its ...
The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...
A study by HE Zhuohao's team from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, has revealed the critical role of the "fuzzy coat" of ...
SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...
This interaction not only helps the virus evade immune cells but may also contribute to the dangerous ... This was strange ...
There are two categories of lymphocytes, known as B lymphocytes and T lymphocytes. People commonly refer to these as B cells and T cells. The job of T cells is to help the body kill cancer cells ...
T-Mobile is the third-largest wireless carrier in the United States, and its popularity is largely due to its network coverage and the wide range of tempting offers available. These range from T ...
There are two main types of lymphocytes, called B cells and T cells. But the kind involved in this type of lymphoma are B cells. These cells make antibodies, which are proteins that help your body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results